Hao Ding

Hao Ding is the Chief Executive Officer at Ividence Inc., a healthcare-AI company focused on real-world evidence generation, causal inference, and privacy-preserving AI applications. They previously served as Group Product Manager at IMO Health (2023–2024) and as Director of Operations at Melax Technologies Inc. (2018–2023). Their earlier roles included Graduate Student Instructor (2002–2003) and Graduate Student Research Assistant (2003–2009) at the University of Michigan's Biophysics Research Division, with postdoctoral positions at Rice University (2009–2011) and UTHealth (2013–2017). They earned a Ph.D. from the University of Michigan (2002–2009) and a B.S. from Nanjing University (1998–2002).